2. Johnson D.C., Vukina J., Smith A.B. et al. Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate. J. Urol. 2015;193(1):30–35. Doi: 10.1016/j.juro.2014.07.102.

3. Hollingsworth J.M., Miller D.C., Daignault S. et al. Rising incidence of small renal masses: a need to reassess treatment effect. J. National Cancer Institute. 2006;98(18):1331–1334. Doi: 10.1093/jnci/djj362 .

4. Hancock S.B., Georgiades C.S. Kidney Cancer. Cancer J. 2016;22(6):387–392 Doi: 10.1097/PPO.0000000000000225.

5. Kane C.J., Mallin K., Ritchey J. et al. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008;113(1):78–83. Doi: 10.1002/cncr.23518.

6. Robson C.J., Churchill B.M., Anderson W. The results of radical nephrectomy for renal cell carcinoma. J. Urol. 1969;101(3):297–301.

7. Sun M., Shariat S.F., Cheng C. et al. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur. Urol. 2011;60(4):644–661. Doi: 10.1016/j.eururo.2011.06.041.

8. Van Poppel H., Da Pozzo L., Albrecht W. et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur. Urol. 2011;59(4):543–552. Doi: 10.1016/j.eururo.2010.12.013.

9. Capitanio U., Terrone C., Antonelli A. et al. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. Eur. Urol. 2015;67(4):683–689. Doi: 10.1016/j.eururo.2014.09.027.

10. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine reviews 2000;21(6):697–738. Doi: 10.1210/edrv.21.6.0415.

11. Mariman E.C., Wang P. Adipocyte extracellular matrix composition, dynamics and role in obesity. Cellular and molecular life sciences: CMLS. 2010;67(8):1277–1292. Doi: 10.1007/s00018-010-0263-4.

12. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. The British journal of nutrition. 2004;92(3):347–355.

13. Adamczak M., Wiecek A. The adipose tissue as an endocrine organ. Seminars in nephrology. 2013;33(1):2–13. Doi: 10.1016/j.semnephrol.2012.12.008.

14. Marin P., Andersson B., Ottosson M. et al. The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism: clinical and experimental. 1992;41(11):1242–1248. Doi: 10.1016/0026-0495(92)90016-4.

15. Zhu Y., Wang H.K., Zhang H.L., et al. Visceral obesity and risk of high grade disease in clinical t1a renal cell carcinoma. The Journal of urology 2013;189(2):447–453. Doi: 10.1016/j.juro.2012.09.030.

16. Monteiro R., Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators of inflammation 2010;2010. Doi: 10.1155/2010/289645.

17. Neels J.G., Olefsky J.M. Inflamed fat: what starts the fire? J. Clin. Invest. 2006;116(1):33–35. Doi: 10.1172/JCI27280.

18. Timar O., Sestier F., Levy E. Metabolic syndrome X: a review. The Canadian journal of cardiology. 2000;16(6):779–789.

19. White W.M., Derweesh I.H. Editorial comment. Urology 2013;81(6):1230–1231. Doi: 10.1016/j.urology.2012.12.058.

20. Bylund J.R., Qiong H., Crispen P.L., et al. Association of clinical and radiographic features with perinephric «sticky» fat. J. Endourol. 2013;27(3):370–373. Doi: 10.1089/end.2012.0205.

21. Davidiuk A.J., Parker A.S., Thomas C.S., et al. Mayo adhesive probability score: an accurate image-based scoring system to predict adherent perinephric fat in partial nephrectomy. Eur. Urol. 2014;66(6):1165–1171. Doi: 10.1016/j.eururo.2014.08.054.

22. Sun K., Tordjman J., Clement K., et al. Fibrosis and adipose tissue dysfunction. Cell metabolism, 2013;18(4):470–477. Doi: 10.1016/j.cmet.2013.06.016.

23. Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. The New England journal of medicine 1986;315(26):1650–1659. Doi: 10.1056/NEJM198612253152606.

24. Lee S.M., Robertson I., Stonier T., et al. Contemporary outcomes and prediction of adherent perinephric fat at partial nephrectomy: a systematic review. Scand. J. Urol. 2017;51(6):429–434. Doi: 10.1080/21681805.2017.1357656.

25. Kocher N.J., Kunchala S., Reynolds C., et al. Adherent perinephric fat at minimally invasive partial nephrectomy is associated with adverse peri-operative outcomes and malignant renal histology. BJU international 2016;117(4):636–641. Doi: 10.1111/bju.13378.

26. Zheng Y., Espiritu P., Hakky T., et al. Predicting ease of perinephric fat dissection at time of open partial nephrectomy using preoperative fat density characteristics. BJU international 2014;114(6):872–880. Doi: 10.1111/bju.12579.

27. Macleod L.C., Hsi R.S., Gore J.L., et al. Perinephric fat thickness is an independent predictor of operative complexity during robot-assisted partial nephrectomy. J. Endourol. 2014;28(5):587–591. Doi: 10.1089/end.2013.0647.

28. Khene Z.E., Peyronnet B., Mathieu R., et al. Analysis of the impact of adherent perirenal fat on peri-operative outcomes of robotic partial nephrectomy. World journal of urology 2015;33(11):1801–1806. Doi: 10.1007/s00345-015-1500-0.

29. Kawamura N., Saito K., Inoue M., et al. Adherent Perinephric Fat in Asian Patients: Predictors and Impact on Perioperative Outcomes of Partial Nephrectomy. Urologia internationalis 2018;101(4):437–442. Doi: 10.1159/000494068.

30. Dariane C., Le Guilchet T., Hurel S., et al. Prospective assessment and histological analysis of adherent perinephric fat in partial nephrectomies. Urologic oncology 2017;35(2):39 e9–39 e17. Doi: 10.1016/j.urolonc.2016.09.008.

31. Ishiyama R., Kondo T., Takagi T., et al. Impact of the Mayo Adhesive Probability Score on the Complexity of Robot-Assisted Partial Nephrectomy. J. Endourol. 2018;32(10):928–933. Doi: 10.1089/end.2017.0779.

32. Eisner B.H., Zargooshi J., Berger A.D., et al. Gender differences in subcutaneous and perirenal fat distribution. Surgical and radiologic anatomy: SRA 2010;32(9):879–882. Doi: 10.1007/s00276-010-0692-7.

33. Renehan A.G., Tyson M., Egger M., et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371(9612):569–578. Doi: 10.1016/S0140-6736(08)60269-X.

34. Aboumarzouk O.M., Stein R.J., Haber G.P., et al. Laparoscopic partial nephrectomy in obese patients: a systematic review and meta-analysis. BJU international 2012;110(9):1244–1250. Doi: 10.1111/j.1464-410X.2012.11094.x.

35. Rogde A.J., Gudbrandsdottir G., Hjelle K.M., et al. Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma. Scandinavian journal of urology and nephrology 2012;46(5):348–357. Doi: 10.3109/00365599.2012.678382.

36. Martin L., Rouviere O., Bezza R., et al. Mayo Adhesive Probability Score Is an Independent Computed Tomography Scan Predictor of Adherent Perinephric Fat in Open Partial Nephrectomy. Urology 2017;103:124–128. Doi: 10.1016/j.urology.2016.11.043.

37. Khene Z.E., Bensalah K., Largent A., et al. Role of quantitative computed tomography texture analysis in the prediction of adherent perinephric fat. World J. Urol. 2018;36(10):1635–1642. Doi: 10.1007/s00345-018-2292-9.

38. House M.G., Fong Y., Arnaoutakis D.J., et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2008;12(2):270–278. Doi: 10.1007/s11605-007-0421-7.

39. Kim S., Choi S.K., Lee S.M., et al. Predictive Value of Preoperative Unenhanced Computed Tomography During Ureteroscopic Lithotripsy: A Single Institute’s Experience. Korean J. urol. 2013;54(11):772–777. Doi: 10.4111/kju.2013.54.11.772.

40. Thiel D.D., Davidiuk A.J., Meschia C., et al. Mayo Adhesive Probability Score Is Associated With Localized Renal Cell Carcinoma Progression-free Survival. Urology. 2016;89:54–60. Doi: 10.1016/j.urology.2015.10.034.

41. Huang H., Chen S., Li W., et al. High perirenal fat thickness predicts a poor progression-free survival in patients with localized clear cell renal cell carcinoma. Urologic oncology 2018;36(4):157 e1–57 e6. Doi: 10.1016/j.urolonc.2017.12.011.

42. Bernstein A.P., Fram E.B., Sankin A., et al. A comparison of perinephric fat surface area and Mayo Adhesive Probability score in predicting malignancy in T1 renal masses. Urologic oncology 2018;36(11):499 e17–99 e22. Doi: 10.1016/j.urolonc.2018.07.018.